Trials / Completed
CompletedNCT02281630
Phase II Dose-Finding Study of KWA-0711 in Patients With Chronic Constipation (CC)
Phase II, Randomized, Placebo-controlled, Double-blind, Parallel-group Study of KWA-0711 Administered Orally for 4 Weeks to Evaluate Its Efficacy and Safety, and to Determine Its Optimal Dose in Patients With Chronic Constipation (CC)
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 388 (actual)
- Sponsor
- Kissei Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- —
Summary
The purpose of this study is to evaluate the efficacy and safety of KWA-0711, and to determine its optimal dose in Chronic Constipation (CC) patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | KWA-0711 | |
| DRUG | Placebo |
Timeline
- Start date
- 2014-10-15
- Primary completion
- 2015-04-28
- First posted
- 2014-11-03
- Last updated
- 2017-05-22
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT02281630. Inclusion in this directory is not an endorsement.